These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 10753187)

  • 21. Overexpression of the human EGF receptor confers an EGF-dependent transformed phenotype to NIH 3T3 cells.
    Di Fiore PP; Pierce JH; Fleming TP; Hazan R; Ullrich A; King CR; Schlessinger J; Aaronson SA
    Cell; 1987 Dec; 51(6):1063-70. PubMed ID: 3500791
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elevated levels of ornithine decarboxylase cooperate with Raf/ERK activation to convert normal keratinocytes into invasive malignant cells.
    Hayes CS; DeFeo K; Lan L; Paul B; Sell C; Gilmour SK
    Oncogene; 2006 Mar; 25(10):1543-53. PubMed ID: 16278677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Down-regulation of type I protein kinase A by transfection of human breast cancer cells with an epidermal growth factor receptor antisense expression vector.
    Ciardiello F; Dixit M; di Isernia G; Damiano V; Bianco R; Bianco AR; Arteaga CL; Tortora G
    Breast Cancer Res Treat; 1998 Jan; 47(1):57-62. PubMed ID: 9493976
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of an ornithine decarboxylase dominant-negative mutant reverses eukaryotic initiation factor 4E-induced cell transformation.
    Shantz LM; Coleman CS; Pegg AE
    Cancer Res; 1996 Nov; 56(22):5136-40. PubMed ID: 8912847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overproduction of ornithine decarboxylase caused by relief of translational repression is associated with neoplastic transformation.
    Shantz LM; Pegg AE
    Cancer Res; 1994 May; 54(9):2313-6. PubMed ID: 8162572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of ornithine decarboxylase gene expression by the Wilms' tumor suppressor WT1.
    Moshier JA; Skunca M; Wu W; Boppana SM; Rauscher FJ; Dosescu J
    Nucleic Acids Res; 1996 Mar; 24(6):1149-57. PubMed ID: 8604351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transformation by H-ras can result in aberrant regulation of ornithine decarboxylase gene expression by transforming growth factor-beta(1).
    Hurta RA; Lee J; Voskas D
    J Cell Biochem; 2001; 81(1):39-55. PubMed ID: 11180396
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reversible regulation of the transformed phenotype of ornithine decarboxylase- and ras-overexpressing cells by dominant-negative mutants of c-Jun.
    Kielosto M; Nummela P; Katainen R; Leaner V; Birrer MJ; Hölttä E
    Cancer Res; 2004 Jun; 64(11):3772-9. PubMed ID: 15172983
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumour promoter mediated altered expression and regulation of ornithine decarboxylase and S-adenosylmethionine decarboxylase in H-ras-transformed fibrosarcoma cell lines.
    Voskas D; Mader R; Lee J; Hurta RA
    Biochem Cell Biol; 2001; 79(1):69-81. PubMed ID: 11235918
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DNA methylation is not involved in the structural alterations of ornithine decarboxylase or total chromatin of c-Ha-rasVal 12 oncogene-transformed NIH-3T3 fibroblasts.
    Laitinen J; Saris P; Hölttä E
    J Cell Biochem; 1995 Apr; 57(4):670-9. PubMed ID: 7615652
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transforming growth factor-alpha short-circuits downregulation of the epidermal growth factor receptor.
    Ouyang X; Gulliford T; Huang G; Epstein RJ
    J Cell Physiol; 1999 Apr; 179(1):52-7. PubMed ID: 10082132
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recycling of EGFR and ErbB2 is associated with impaired Hrs tyrosine phosphorylation and decreased deubiquitination by AMSH.
    Meijer IM; van Rotterdam W; van Zoelen EJ; van Leeuwen JE
    Cell Signal; 2012 Nov; 24(11):1981-8. PubMed ID: 22800866
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor promoter-induced ornithine decarboxylase gene expression occurs independently of AP-1 activation.
    Jansen AP; Colburn NH; Verma AK
    Oncogene; 1999 Oct; 18(42):5806-13. PubMed ID: 10523861
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transformation of NIH 3T3 cells with basic fibroblast growth factor or the hst/K-fgf oncogene causes downregulation of the fibroblast growth factor receptor: reversal of morphological transformation and restoration of receptor number by suramin.
    Moscatelli D; Quarto N
    J Cell Biol; 1989 Nov; 109(5):2519-27. PubMed ID: 2553749
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Involvement of Ca(2+)-calmodulin in platelet-derived growth factor-, fibroblast growth factor-, and insulin-induced ornithine decarboxylase in NIH-3T3 cells.
    Katori T; Yasuda H; Fukuda H; Kimura S
    Metabolism; 1994 Jan; 43(1):4-10. PubMed ID: 8289674
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Altered ornithine decarboxylase and S-adenosylmethionine decarboxylase expression and regulation in mouse fibroblasts transformed with oncogenes or constitutively active Mitogen-Activated Protein (MAP) kinase kinase.
    Hurta RA
    Mol Cell Biochem; 2000 Dec; 215(1-2):81-92. PubMed ID: 11204459
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synergistic interaction of p185c-neu and the EGF receptor leads to transformation of rodent fibroblasts.
    Kokai Y; Myers JN; Wada T; Brown VI; LeVea CM; Davis JG; Dobashi K; Greene MI
    Cell; 1989 Jul; 58(2):287-92. PubMed ID: 2568888
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcriptional and translational control of ornithine decarboxylase during Ras transformation.
    Shantz LM
    Biochem J; 2004 Jan; 377(Pt 1):257-64. PubMed ID: 14519103
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of ornithine decarboxylase during oncogenic transformation: mechanisms and therapeutic potential.
    Shantz LM; Levin VA
    Amino Acids; 2007 Aug; 33(2):213-23. PubMed ID: 17443268
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cells transformed by ODC, c-Ha-ras and v-src exhibit MAP kinase/Erk-independent constitutive phosphorylation of Sos, Raf and c-Jun activation domain, and reduced PDGF receptor expression.
    Paasinen-Sohns A; Hölttä E
    Oncogene; 1997 Oct; 15(16):1953-66. PubMed ID: 9365242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.